The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
Linkage of gut microbiome with cognition in hepatic encephalopathy
Open accessAbstract
Hepatic encephalopathy (HE) has been related to gut bacteria and inflammation in the setting of intestinal barrier dysfunction. We aimed to link the gut microbiome with cognition and inflammation in HE using a systems biology approach. Multitag pyrosequencing (MTPS) was performed on stool of cirrhotics and age-matched controls. Cirrhotics with/without HE underwent cognitive testing, inflammatory cytokines, and endotoxin analysis. Patients with HE were compared with those without HE using a correlation-network analysis. A select group of patients with HE (n = 7) on lactulose underwent stool MTPS before and after lactulose withdrawal over 14 days. Twenty-five patients [17 HE (all on lactulose, 6 also on rifaximin) and 8 without HE, age 56 ± 6 yr, model for end-stage liver disease score 16 ± 6] and ten controls were included. Fecal microbiota in cirrhotics were significantly different (higher Enterobacteriaceae, Alcaligeneceae, and Fusobacteriaceae and lower Ruminococcaceae and Lachnospiraceae) compared with controls. We found altered flora (higher Veillonellaceae), poor cognition, endotoxemia, and inflammation (IL-6, TNF-α, IL-2, and IL-13) in HE compared with cirrhotics without HE. In the cirrhosis group, Alcaligeneceae and Porphyromonadaceae were positively correlated with cognitive impairment. Fusobacteriaceae, Veillonellaceae, and Enterobacteriaceae were positively and Ruminococcaceae negatively related to inflammation. Network-analysis comparison showed robust correlations (all P < 1E-5) only in the HE group between the microbiome, cognition, and IL-23, IL-2, and IL-13. Lactulose withdrawal did not change the microbiome significantly beyond Fecalibacterium reduction. We concluded that cirrhosis, especially when complicated with HE, is associated with significant alterations in the stool microbiome compared with healthy individuals. Specific bacterial families (Alcaligeneceae, Porphyromonadaceae, Enterobacteriaceae) are strongly associated with cognition and inflammation in HE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the bacterial family Porphyromonadaceae has been linked to declines in cognition and affective disorders”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Bajaj et al., 2012
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In individuals with alcohol addiction, drinking can disrupt intestinal barrier function, also known as intestinal leakage [11, 12].”
From Research protocol of the efficacy of probiotics for the treatment of alcohol use disorder among adult males: A comparison with placebo and acceptance and commitment therapy in a randomized controlled trial (2023) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Nucleic acid techniques in bacterial systematics
Stackebrandt, E. S., & Goodfellow, M. (1991) · Wiley eBooks · Cited by 9,460
Lane, D. (1991) · Medical Entomology and Zoology · Cited by 8,190
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Normal gut microbiota modulates brain development and behavior
Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., & Pettersson, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010529108 · Cited by 3,228
Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples
White, J. R., Nagarajan, N., & Pop, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000352 · Cited by 1,599
Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S. (2011) · Gut · doi:10.1136/gut.2010.223263 · Cited by 1,063
Characterization of fecal microbial communities in patients with liver cirrhosis
Chen, Y., Yang, F., Lu, H., Wang, B., Chen, Y., Lei, D., Wang, Y., Zhu, B., & Li, L. (2011) · Hepatology · doi:10.1002/hep.24423 · Cited by 1,038
Microbial community profiling for human microbiome projects: Tools, techniques, and challengesPreprint
Hamady, M., & Knight, R. D. (2009) · Genome Research · doi:10.1101/gr.085464.108 · Cited by 1,031
Flagged first, then by citations
2 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 555
Sung, C. M., Lin, Y.-F., Chen, K.-F., Ke, H.-M., Huang, H.-Y., Gong, Y.-N., Tsai, W.-S., You, J.-F., Lu, M. J., Cheng, H.-T., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.04.008 · Cited by 127
Manderino, L., Carroll, I., Azcarate-Peril, M. A., Rochette, A., Heinberg, L., Peat, C., Steffen, K., Mitchell, J., & Gunstad, J. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617717000492 · Cited by 125
Acute-on-chronic liver failure: Terminology, mechanisms and management
Vinay Kumar, B. R., & Sarin, S. K. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0103 · Cited by 129
Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature
Pijls, K. E., Jonkers, D. M. A. E., Elamin, E. E., Masclee, A., & Koek, G. H. (2013) · Liver International · doi:10.1111/liv.12271 · Cited by 124
Human Microbiome and its Association With Health and Diseases
Thani, A. A. A., Marei, H. E. S., Hamdi, W. S., Nasrallah, G. K., Zowalaty, M. E. E., Khodor, S. A., Al‐Asmakh, M., Aziz, H. A., & Cenciarelli, C. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25284 · Cited by 130
Giuffrè, M., Campigotto, M., Campisciano, G., Comar, M., & Crocè, L. S. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00161.2019 · Cited by 122
Riedel, B., Browne, K., & SILBERT, B. S. (2013) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000032 · Cited by 122
Bajaj, J. S., Acharya, C., Fagan, A., White, M. B., Gavis, E. A., Heuman, D. M., Hylemon, P. B., Fuchs, M. A., Puri, P., Schubert, M. L., et al. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0085-9 · Cited by 124
Self-citationSerum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis
Wang, X., Xie, G., Zhao, A., Zheng, X., Huang, F., Wang, Y., Yao, C., Jia, W. P., & Liu, P. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00217 · Cited by 118
Recent advances in the treatment of hyperammonemia
Matoori, S., & Leroux, J. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.009 · Cited by 115
Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update
Fukui, H. (2020) · Gut and Liver · doi:10.5009/gnl20032 · Cited by 121
Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice
Kang, D. J., Betrapally, N. S., Ghosh, S., Sartor, R. B., Hylemon, P. B., Gillevet, P. M., Sanyal, A. J., Heuman, D. M., Carl, D. E., Zhou, H., et al. (2016) · Hepatology · doi:10.1002/hep.28696 · Cited by 116
Self-citationAmmonia-Lowering Strategies for the Treatment of Hepatic Encephalopathy
Rose, C. F. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.112 · Cited by 111
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease
Hartmann, P., Chen, W., & Schnabl, B. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00402 · Cited by 110
Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut
Ridlon, J. M., Kang, D.-J., Hylemon, P. B., & Bajaj, J. S. (2015) · Digestive Diseases · doi:10.1159/000371678 · Cited by 109
Self-citationAcetate reprograms gut microbiota during alcohol consumption
Martino, C., Zaramela, L. S., Gao, B., Embree, M., Tarasova, J., Parker, S. J., Wang, Y., Chu, H., Chen, P., Lee, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31973-2 · Cited by 110
Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis
Bajaj, J. S., Fagan, A., Sikaroodi, M., White, M. B., Sterling, R. K., Gilles, H., Heuman, D. M., Stravitz, R. T., Matherly, S. C., Siddiqui, M. S., et al. (2017) · Liver Transplantation · doi:10.1002/lt.24754 · Cited by 103
Self-citationGut Microbiota Interaction with the Central Nervous System throughout Life
Ojeda, J., Ávila, A., & Vidal, P. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061299 · Cited by 112
Gut microbiome and liver disease
Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.005 · Cited by 106
Self-citationKaji, K., Takaya, H., Saikawa, S., Furukawa, M., Sato, S., Kawaratani, H., Kitade, M., Moriya, K., Namisaki, T., Akahane, T., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i47.8355 · Cited by 107
Marques, T. M., Wall, R., O’Sullivan, Ó., Fitzgerald, G. F., Shanahan, F., Quigley, E. M. M., Cotter, P. D., Cryan, J. F., Dinan, T. G., Ross, R. P., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114514004206 · Cited by 103
Decompensated cirrhosis and microbiome interpretation
Bajaj, J. S., Betrapally, N. S., & Gillevet, P. M. (2015) · Nature · doi:10.1038/nature14851 · Cited by 100
Self-citationEarly Life Experience and Gut Microbiome
Cong, X. S., Henderson, W. A., Graf, J., & McGrath, J. M. (2015) · Advances in Neonatal Care · doi:10.1097/anc.0000000000000191 · Cited by 106
Microbiota, a key player in alcoholic liver disease
Cassard, A.-M., & Ciocan, D. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0067 · Cited by 100
Vrieze, A., de Groot, P. F., Kootte, R. S., Knaapen, M., van Nood, E., & Nieuwdorp, M. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.003 · Cited by 102
Iebba, V., Guerrieri, F., Gregorio, V. D., Levrero, M., Gagliardi, A., Santangelo, F., Sobolev, A. P., Circi, S., Giannelli, V., Mannina, L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26509-y · Cited by 101
Baltazar-Díaz, T. A., González-Hernández, L. A., Aldana-Ledesma, J. M., Rodríguez, M. P., Vega‐Magaña, N., Zepeda‐Morales, A. S. M., López-Roa, R. I., del Toro‐Arreola, S., Martínez‐López, E., Salazar-Montes, A. M., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10061231 · Cited by 104
Integrative inflammasome activity in the regulation of intestinal mucosal immune responses
Elinav, E., Henao‐Mejia, J., & Flavell, R. A. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.115 · Cited by 101
Gut Microbiota and Complications of Liver Disease
Acharya, C., & Bajaj, J. S. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.013 · Cited by 101
Self-citationA longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy
Bajaj, J. S., Gillevet, P. M., Patel, N. R., Ahluwalia, V., Ridlon, J. M., Kettenmann, B., Schubert, C. M., Sikaroodi, M., Heuman, D. M., Crossey, M. M. E., et al. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9303-0 · Cited by 95
Self-citationZhou, S., Wang, Y., Jacoby, J. J., Jiang, Y., Zhang, Y., & Yu, L. L. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b01803 · Cited by 94
Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition
Kang, D. J., Kakiyama, G., Betrapally, N. S., Herzog, J., Nittono, H., Hylemon, P. B., Zhou, H., Carroll, I. M., Yang, J., Gillevet, P. M., et al. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.44 · Cited by 97
Self-citationChen, R., Wang, J., Zhan, R., Zhang, L., & Wang, X. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112139 · Cited by 97
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications
Ponziani, F. R. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12322 · Cited by 90
Gut microbiota regulates key modulators of social behavior
Parashar, A., & Udayabanu, M. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.002 · Cited by 88
Wang, J. Y., Bajaj, J. S., Wang, J. B., Shang, J., Zhou, X., Guo, X., Zhu, X., Meng, L. N., Jiang, H. X., Mi, Y. Q., et al. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12816 · Cited by 87
Self-citationAn investigation into physical frailty as a link between the gut microbiome and cognitive health
Verdi, S., Jackson, M. A., Beaumont, M., Bowyer, R. C. E., Bell, J. T., Spector, T. D., & Steves, C. J. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00398 · Cited by 82
Tsiaoussis, G. I. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i17.2058 · Cited by 83
Cichoż‐Lach, H. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i1.26 · Cited by 82
Bajaj, J. S., Sikaroodi, M., Fagan, A., Heuman, D. M., Gilles, H., Gavis, E. A., Fuchs, M. A., González‐Maeso, J., Nizam, S., Gillevet, P. M., et al. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00194.2019 · Cited by 84
Self-citationImmunoglobulin A and liver diseases
Inamine, T., & Schnabl, B. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-017-1400-8 · Cited by 76
The antibody/microbiota interface in health and disease
Sterlin, D., Fadlallah, J., Slack, E. M. C., & Gorochov, G. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0192-y · Cited by 77
Intestinal virome and therapeutic potential of bacteriophages in liver disease
Hsu, C. L., Duan, Y., Fouts, D. E., & Schnabl, B. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.08.003 · Cited by 78
Bloom, P. P., Donlan, J., Soto, M. T., Daidone, M., Hohmann, E. L., & Chung, R. T. (2022) · Hepatology Communications · doi:10.1002/hep4.1950 · Cited by 76
Bruce-Keller, A. J., Fernandez-Kim, S.-O., Townsend, R. L., Kruger, C., Carmouche, R., Newman, S., Salbaum, J. M., & Berthoud, H.-R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175577 · Cited by 76
Gut Ruminococcaceae levels at baseline correlate with risk of antibiotic-associated diarrhea
Gu, X., Sim, J. X. Y., Lee, W. L., Liang, C., Chan, Y. F. Z., Chang, E. D., Teh, Y. E., Zhang, A., Armas, F., Chandra, F., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103644 · Cited by 79
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Zhang, Y., Li, Z.-J., Gou, H.-Z., Song, X., & Zhang, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.945368 · Cited by 77
Shang, Q., Liu, S., Liu, H., Mahfuz, S. U., & Piao, X. (2021) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-021-00573-3 · Cited by 72
Arab, J. P., Arrese, M. A., & Shah, V. H. (2019) · Hepatology Research · doi:10.1111/hepr.13473 · Cited by 76
The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders
Losurdo, G., D’Abramo, F. S., Indellicati, G., Lillo, C., Ierardi, E., & Leo, A. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103531 · Cited by 71
Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis
Shamsaddini, A., Gillevet, P. M., Acharya, C., Fagan, A., Gavis, E. A., Sikaroodi, M., McGeorge, S., Khoruts, A., Albhaisi, S. A. M., Fuchs, M. A., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.04.013 · Cited by 73
Self-citationThe Link between Gut Microbiota and Hepatic Encephalopathy
Won, S., Oh, K., Gupta, H., Ganesan, R., Sharma, S. P., Jeong, J., Yoon, S. J., Jeong, M. K., Min, B. H., Hyun, J. Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168999 · Cited by 69
Anand, S. K., Ahmad, M. H., Sahu, M. R., Subba, R., & Mondal, A. C. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01308-2 · Cited by 75
Cellular Pathogenesis of Hepatic Encephalopathy: An Update
Lu, K. (2023) · Biomolecules · doi:10.3390/biom13020396 · Cited by 68
Microbiome and Cognitive Impairment: Can Any Diets Influence Learning Processes in a Positive Way?
Novotný, M., Klímová, B., & Vališ, M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00170 · Cited by 68
Nath, A., Haktanirlar, G., Varga, Á., Molnár, M. A., Albert, K., Galambos, I., Koris, A. K., & Vatai, G. N. (2018) · Medicina · doi:10.3390/medicina54020018 · Cited by 69
Zhu, H., Hao, H., & Yu, L. (2023) · BMC Biology · doi:10.1186/s12915-023-01796-8 · Cited by 66
Stravitz, R. T., Sanyal, A. J., REISCH, J. S., Bajaj, J. S., Mirshahi, F., Cheng, J., Lee, W. M., & The Acute Liver Failure Study Group (2013) · Liver International · doi:10.1111/liv.12214 · Cited by 68
Self-citationBajaj, J. S., Fagan, A., White, M. B., Wade, J. B., Hylemon, P. B., Heuman, D. M., Fuchs, M. A., John, B. V., Acharya, C., Sikaroodi, M., et al. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000102 · Cited by 69
Self-citationThe Intestinal Microbiota in Chronic Liver Disease
Henao‐Mejia, J., Elinav, E., Thaiss, C. A., & Flavell, R. A. (2013) · Advances in immunology · doi:10.1016/b978-0-12-410524-9.00003-7 · Cited by 70
Gut Microbiota and Host Reaction in Liver Diseases
Fukui, H. (2015) · Microorganisms · doi:10.3390/microorganisms3040759 · Cited by 64
Horvatits, T., Drolz, A., Roedl, K., Rutter, K., Ferlitsch, A., Fauler, G., Trauner, M. A., & Fuhrmann, V. (2016) · Liver International · doi:10.1111/liv.13201 · Cited by 65
Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trial
Bajaj, J. S., Fagan, A., Gavis, E. A., Sterling, R. K., Gallagher, M. L., Lee, H. M., Matherly, S. C., Siddiqui, M. S., Bartels, A., Mousel, T., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2024.12.047 · Cited by 68
Self-citationChae, J. P., Pajarillo, E. A. B., Oh, J. K., Kim, H., & Kang, D. (2016) · Microbial Biotechnology · doi:10.1111/1751-7915.12370 · Cited by 62
The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma
Sanduzzi‐Zamparelli, M., Rocco, A., Compare, D., & Nardone, G. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617705576 · Cited by 60
Lactulose: Patient- and dose-dependent prebiotic properties in humans
Ruszkowski, J., & Witkowski, J. M. (2019) · Anaerobe · doi:10.1016/j.anaerobe.2019.06.002 · Cited by 64
Gut Microbiota and Relevant Metabolites Analysis in Alcohol Dependent Mice
Wang, G., Liu, Q., Guo, L., Zeng, H., Ding, C., Zhang, W., Xu, D., Wang, X., Qiu, J., Dong, Q., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01874 · Cited by 62
SCNIC: Sparse correlation network investigation for compositional data
Shaffer, M., Thurimella, K., Sterrett, J. D., & Lozupone, C. (2022) · Molecular Ecology Resources · doi:10.1111/1755-0998.13704 · Cited by 68
Exploring the microbiota-gut-brain axis: impact on brain structure and function
Yassin, L. K., Nakhal, M. M., Alderei, A., Almehairbi, A., Mydeen, A. B., Akour, A. A., & Hamad, M. I. K. (2025) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2025.1504065 · Cited by 64
Gut microbiome-brain-cirrhosis axis
Smith, M. L., Wade, J. B., Wolstenholme, J. T., & Bajaj, J. S. (2023) · Hepatology · doi:10.1097/hep.0000000000000344 · Cited by 65
Self-citationElderly patients have an altered gut-brain axis regardless of the presence of cirrhosis
Bajaj, J. S., Ahluwalia, V., Steinberg, J. L., Hobgood, S. E., Boling, P. A., Godschalk, M., Habib, S., White, M. B., Fagan, A., Gavis, E. A., et al. (2016) · Scientific Reports · doi:10.1038/srep38481 · Cited by 60
Self-citationRole of bile acids in liver diseases mediated by the gut microbiome
Shao, J., Ge, T., Chen, S., Wang, G., Yang, Q., Huang, C., Xu, L., & Chen, Z. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i22.3010 · Cited by 61
Identification and Characterization of Major Bile Acid 7α-Dehydroxylating Bacteria in the Human Gut
Kim, K. H., Park, D., Jia, B., Baek, J. H., Hahn, Y., & Jeon, C. O. (2022) · mSystems · doi:10.1128/msystems.00455-22 · Cited by 66
Gut microbiota and hepatic encephalopathy
Dhiman, R. K. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9388-0 · Cited by 58
Zhong, X., Cui, P., Jiang, J., Ning, C., Liang, B., Zhou, J., Li, T., Zhang, Y., Lei, T., Zuo, T., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.649060 · Cited by 58
Mouli, V. P., Benjamin, J., Singh, M. B., Kalaivani, M., Garg, S. K., Saraya, A., & Joshi, Y. K. (2014) · Hepatology Research · doi:10.1111/hepr.12429 · Cited by 57
Huang, R., Li, T., Ni, J., Bai, X., Gao, Y., Li, Y., Zhang, P., & Gong, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01008 · Cited by 58
Chinese guidelines on management of hepatic encephalopathy in cirrhosis
Xu, X., Ding, H.-G., Li, W., Jia, J., Wei, L., Duan, Z., Liu, Y., Linghu, E., Zhuang, H., & Chinese Society Of Hepatology (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i36.5403 · Cited by 57
Intestinal flora plays a role in the progression of hepatitis-cirrhosis-liver cancer
Liu, S., & Yang, X. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1140126 · Cited by 67
The Intestinal Microbiota and Liver Disease
Bajaj, J. S., Hylemon, P. B., & Younossi, Z. M. (2012) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2012.3 · Cited by 57
Self-citationInflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis
Luo, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11815 · Cited by 60
Foodomics as part of the host-microbiota-exposome interplay
Putignani, L., & Dallapiccola, B. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.04.033 · Cited by 56
Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis
Nishimura, N., Kaji, K., Kitagawa, K., Sawada, Y., Furukawa, M., Ozutsumi, T., Fujinaga, Y., Tsuji, Y., Takaya, H., Kawaratani, H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136921 · Cited by 58
Structure, functions, and diversity of the healthy human microbiome
Ahrodia, T., Das, S., Bakshi, S., & Das, B. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.07.003 · Cited by 55
Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota
Garcovich, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i46.6693 · Cited by 56
Pathophysiology of Hepatic Encephalopathy
Jaffe, A., Lim, J. K., & Jakab, S. (2020) · Clinics in Liver Disease · doi:10.1016/j.cld.2020.01.002 · Cited by 54
Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
Sarangi, A. N., Goel, A., Singh, A., Sasi, A., & Aggarwal, R. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0683-9 · Cited by 56
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis
Campion, D., Giovo, I., Ponzo, P., Saracco, G. M., Balzola, F. A., & Alessandria, C. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i6.489 · Cited by 57
The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis
Zhu, R., Liu, L., Zhang, G., Dong, J., Ren, Z., & Li, Z. (2023) · Bioscience Reports · doi:10.1042/bsr20222524 · Cited by 57
Quorum Sensing Peptides Selectively Penetrate the Blood-Brain Barrier
Wynendaele, E., Verbeke, F., Stalmans, S., Gevaert, B., Janssens, Y., de Wiele, C. V., Peremans, K. Y., Burvenich, C., & Spiegeleer, B. M. J. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142071 · Cited by 53
Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step
Fukui, H. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00008 · Cited by 55
Role of the intestinal microbiome in liver fibrosis development and new treatment strategies
Zhou, R., Fan, X., & Schnabl, B. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.005 · Cited by 53
Hassouneh, R., & Bajaj, J. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020330 · Cited by 53
Self-citationSharma, V., Garg, S., & Aġġarwal, S. (2013) · The Permanente Journal · doi:10.7812/tpp/12-144 · Cited by 50
Liu, Y., Li, J., Jin, Y., Zhao, L., Zhao, F., Feng, J., Li, A., & Wei, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00963 · Cited by 51
Gut microbiota and the development of pediatric diseases
Lu, C., & Ni, Y. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1082-z · Cited by 50
Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis
Chen, Y., Qin, N., Guo, J., Qian, G., Fang, D., Shi, D., Xu, M., Yang, F., He, Z., Nostrand, J. D. V., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-753 · Cited by 49
Rethinking the bile acid/gut microbiome axis in cancer
Phelan, J. P., Reen, F. J., Caparros-Martin, J. A., O’Connor, R., & O’Gara, F. (2017) · Oncotarget · doi:10.18632/oncotarget.22803 · Cited by 52
Influence of proton pump inhibitors on microbiota in chronic liver disease patients
Yamamoto, K., Ishigami, M., Honda, T., Takeyama, T., Ito, T., Ishizu, Y., Kuzuya, T., Hayashi, K., Goto, H., & Hirooka, Y. (2019) · Hepatology International · doi:10.1007/s12072-019-09932-9 · Cited by 51
Gut microbiota-related complications in cirrhosis
Gómez‐Hurtado, I. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15624 · Cited by 49
Metadata
- Authors
- Bajaj, J. S., Ridlon, J. M., Hylemon, P. B., Thacker, L. R., Heuman, D. M., Smith, S., Sikaroodi, M., & Gillevet, P. M.
- Affiliations
- Divisions of 1Gastroenterology, Hepatology and Nutrition,
- Virginia Commonwealth University (US)
- George Mason University (US)
- Corresponding author
- Bajaj, Jasmohan S.
- ORCID
- Venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Publisher
- American Physiological Society
- Published
- 2012-01
- Volume
- 302
- Issue
- 1
- Pages
- G168-G175
- ISSN
- 0193-1857 (ISSN-L)
- 1522-1547
- PMC
- PMC3345956
- OpenAlex
- W2058029859
- Cited by
- 547
- References
- 49
- Citations by year
- 2026: 10 · 2025: 30 · 2024: 43 · 2023: 60 · 2022: 40 · 2021: 45 · 2020: 42 · 2019: 49 · 2018: 43 · 2017: 36 · 2016: 34 · 2015: 32 · 2014: 33 · 2013: 25 · 2012: 23
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Physiology-Gastrointestinal and Liver Physiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American College of Gastroenterology
- Virginia Commonwealth University
- National Institute on Alcohol Abuse and Alcoholism (R01AA020203)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK087913)
- National Center for Complementary and Alternative Medicine
- National Center for Complementary and Integrative Health (U01AT004428)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- hepatic encephalopathy, gut microbiota, cognitive impairment, liver cirrhosis, inflammation, endotoxemia, rifaximin, Veillonellaceae, Enterobacteriaceae, Alcaligenaceae, Porphyromonadaceae, inflammatory cytokines, intestinal barrier dysfunction, systems biology
- MeSH terms
- Rifaximin, Cognition Disorders, Endotoxins, Feces, Female, Gastrointestinal Agents, Hepatic Encephalopathy, Humans, Lactulose, Liver Cirrhosis, Male, Middle Aged, Rifamycins, Cytokines, Gastrointestinal Tract, Systems Biology, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
